NYU Langone and NYU Grossman in the News
Study: More parents are skipping standard care for newborns
FOX 5 Health News
Rabia A. De Latour, MD, gastroenterologist and associate professor of medicine at NYU Grossman School of Medicine, discusses a new JAMA study showing that parental refusals of the standard newborn vitamin K injection nearly doubled between 2017 and 2025, rising from 3.1% to 6.8%. Dr. De Latour explains that vitamin K is crucial for blood clotting and preventing severe complications like intracranial and gastrointestinal bleeding. She notes that infants whose parents refuse the shot experience a 47% increase in serious bleeding events, a condition carrying a 20% mortality rate. Despite decades of safety data, she attributes the rise in refusals largely to misinformation on social media.
Also reporting was: The New York Times
11/04/2026
3 ways fidgeting may actually benefit your health
The Washington Post
Fidgeting may offer several minor health benefits, according to recent studies and expert commentary. These small, often unconscious movements can temporarily increase blood flow, help regulate blood sugar after eating, and may improve focus for some individuals. Gillian M. Goddard, MD, an endocrinologist at NYU Langone Health and adjunct assistant professor in the Department of Medicine at NYU Grossman School of Medicine, notes that even minor muscle contractions help absorb glucose, supporting insulin response and stabilizing blood sugar levels. While fidgeting is not a substitute for exercise, experts agree it is better than remaining completely sedentary for long periods.
Also reporting was: Yahoo Life
11/05/2026
Rare diagnosis could explain Lions LB Jack Campbell's neck injury update, spine experts say
USA Today
Following a significant neck injury to Detroit Lions linebacker Jack Campbell, spine experts have weighed in on his diagnosis and recovery. Darryl Lau, MD, a neurosurgeon and director of spinal neurosurgery research at NYU Langone Health’s Spine Center, stated that public updates suggest the player's spinal cord is intact. Dr. Lau explained that the symptoms are consistent with central cord syndrome, a rare injury that affects arm function more than leg function. While he views the progress as positive, Dr. Lau cautioned that Campbell's recovery will be long.
Also reporting was: Aol, Yahoo Sport UK, MSN UK, Marco Eagle, Yahoo Sports
11/05/2026
What will Jets need to see to clear Garrett Wilson from concussion protocol? | The Injury Report
New York Post
Matthew Apicella, DO, a sports orthopedic specialist at NYU Langone Health, joins The Injury Report to discuss the recovery path for New York Jets wide receiver Garrett Wilson. Wilson was placed in concussion protocol, and Dr. Apicella outlines the necessary steps and observations medical staff will need to see for him to be cleared for play.
11/05/2026
Where DNA copying fails can decide how cancer cells respond to PARP inhibitors
Genetic Engineering & Biotechnology News
A new study led by researchers at NYU Langone Health’s Perlmutter Cancer Center pinpoints where on chromosomes DNA copying fails and demonstrates how PARP inhibitors can compromise cancer cell survival by letting damage accumulate at these sites. The research, published in Nature Cell Biology, was co-authored by Eli Rothenberg, PhD, professor in the Department of Biochemistry and Molecular Pharmacology at NYU Grossman School of Medicine, and Dipika Gupta, PhD, a postdoctoral fellow in his lab. The team used a unique imaging approach to identify a 'genomic Achilles’ heel' where replication problems have severe consequences, which could help develop new biomarkers for cancer drug sensitivity.
Also reporting was: News Medical, MSN
11/05/2026
Key gene maintains lifelong supply of bone-healing stem cells
Technology Networks
A new study led by NYU Langone Health researchers found that the gene HOXA10 is required to maintain a lifelong supply of bone-healing stem cells. The research showed that the gene acts as a brake, preventing premature maturation of stem cells into bone-building cells until they are needed for healing. According to corresponding author Philipp Leucht, MD, PhD, the Jyoti Menon Associate Professor of Orthopedic Surgery and vice chair for research in the Department of Orthopedic Surgery at NYU Grossman School of Medicine, mice lacking the gene could not heal fractures properly. These findings establish HOX genes as potential therapeutic targets to enhance bone regeneration.
11/04/2026
Tony-award winner J. Harrison Ghee is hosting this year's NYC kidney walk
The Noon
Tony Award-winning actor J. Harrison Ghee opens up about their personal journey with kidney disease, a condition that runs in their family, and their upcoming role as host of the New York City Kidney Walk at Foley Square. Ghee, who was diagnosed in 2022 and is currently on the kidney transplant list preparing for dialysis, emphasizes the importance of community support and organ donation awareness. Highlighting their medical care, Ghee expressed deep gratitude for the transplant team, noting that they are being cared for by the exceptional specialists at NYU Langone Health.
11/04/2026
8 surprising signs of chronic inflammation doctors say you shouldn't ignore
Good Housekeeping
Priya Jaisinghani, MD, obesity specialist and clinical assistant professor at NYU Langone Health, explains that while inflammatory responses can be protective, chronic inflammation is often linked to diseases such as diabetes and autoimmune conditions. The article distinguishes between acute inflammation, which is temporary, and chronic inflammation, which is persistent and may present with subtle signs. These can include fatigue, skin issues, muscle weakness, cognitive decline, dry eyes, back pain, and bowel problems. The piece also discusses measuring inflammation, potential treatments, and preventive measures like diet and exercise.
Also reporting was: Aol
11/05/2026
The ACR names 18 members to its 2026 Masters Class
The Rheumatologist
The American College of Rheumatology (ACR) has named 18 members to its 2026 Masters Class, one of the highest honors the organization bestows. Among those recognized is Michael Pillinger, MD, professor of medicine, and of biochemistry and molecular pharmacology at NYU Grossman School of Medicine, who is also the rheumatology section chief at the Manhattan Veterans Administration Hospital. This recognition is for members who have made outstanding contributions to rheumatology. Dr. Pillinger said he was deeply honored and that recognition as a Master was something he had never imagined.
11/04/2026
Need for speed: AACR-Industry Roundtable 2026 examines strategies to accelerate drug development
American Association for Cancer Research
The American Association of Cancer Research-Industry Roundtable 2026 examined strategies to accelerate cancer drug development. Manuel Hidalgo Medina, MD, professor at NYU Grossman School of Medicine and co-director of the Gastrointestinal Cancer Center at NYU Langone Health's Perlmutter Cancer Center, chaired the meeting. He emphasized that any efforts to increase speed must not sacrifice evidence or patient benefit. The roundtable explored topics including earlier patient engagement in research, new methodologies to improve preclinical studies, more efficient clinical trial designs like master protocols, and the application of artificial intelligence to streamline the process.
11/04/2026
Blood test could detect lung cancer long before scans
LabRoots
A study in the Journal of Molecular Diagnostics showed a blood test can detect lingering lung cancer traces after surgery before they are visible on scans. Lead investigator Matija Snuderl, MD, professor of pathology and director of molecular pathology at NYU Langone Health, noted liquid biopsies are a critical tool for personalized care. The study on non-small-cell lung cancer found negative tests correlate with sustained remission, helping to avoid overtreatment. Positive results allow for early, targeted intervention, which is associated with better long-term outcomes and survival.
11/04/2026
William Huang, MD, discusses the potential of histotripsy for renal tumors
Urology Times
William C. Huang, MD, professor of urology and radiology at NYU Grossman School of Medicine and chief of urology at Tisch Hospital, NYU Langone Health, discussed the potential of histotripsy for treating renal tumors. He explained that this noninvasive technology uses high-amplitude ultrasound waves to mechanically disrupt tissue without heat, which may limit off-target effects. Histotripsy is currently FDA-approved for liver tumors and has been submitted for approval for renal tumors. Dr. Huang also reviewed the #HOPE4KIDNEY trial, which evaluates the technology in patients with small renal masses, noting that preserving kidney function is a key outcome being assessed.
11/05/2026
Major weight loss reshapes brain structure in people with obesity, one-year study finds
Scienmag
A prospective cohort study at NYU Grossman School of Medicine’s Brain, Obesity & Diabetes Laboratory found that people with obesity who lost substantial excess weight over one year had measurable gains in brain structure. The research, published in Obesity Science & Practice, enrolled 84 adults from programs at NYU Langone Health and NYU Langone Hospital—Brooklyn. Participants who lost at least 40 percent of their excess weight showed significant increases in subcortical gray matter volume. They also experienced considerable improvements in blood sugar control, cholesterol levels, and inflammation markers compared to a non-weight-loss group.
11/05/2026
Participation in stool-based screening program cut colorectal cancer mortality by 43%
Healio Gastroenterology
A Swedish study found participation in a fecal occult blood test screening program was associated with a 43% decline in colorectal cancer mortality. In a perspective piece, Arielle Elmaleh-Sachs, MD, assistant professor in the Departments of Medicine and Population Health at NYU Grossman School of Medicine, writes that the findings underscore the importance of screening uptake in real-world practice. She notes that mailed screening initiatives have the potential to reduce mortality on a population level and that encouraging test completion could prevent substantial deaths.
11/05/2026
Brain activity patterns may predict Alzheimer’s years before memory slips
Yubanet
A Stanford Medicine-led study found that specific brain activity patterns can predict the likelihood of developing Alzheimer’s disease years before cognitive decline. Published in Science Advances, the research developed a scoring system, the Alzheimer’s resilience-vulnerability connectome (ARC), which proved more effective at predicting cognitive decline than genetics and other biomarkers. The findings could lead to earlier interventions for at-risk individuals. Researchers from several institutions, including NYU Grossman School of Medicine, contributed to the study.
11/05/2026
DUOTAP trial: Postdilation sets up TAVR for success
MedPage Today
The DUOTAP trial found that routine postdilation during transcatheter aortic valve replacement (TAVR) with a balloon-expandable platform reduced device asymmetry, paravalvular leak, and hypo-attenuated leaflet thickening. Commenting on the study, Susheel Kodali, MD, interventional cardiologist at NYU Langone Health, highlighted safety concerns with postdilation. He said that echocardiographic and fluoroscopic characteristics will be key to determining which patients should receive the procedure, noting that optimizing valve expansion is the ultimate goal and that current assessment methods need improvement.
Also reporting was: MSN UK
11/04/2026
20-year analysis: Rural patients more likely to die from MI before reaching the hospital
Medscape
A 20-year analysis of over 2.5 million US death certificates revealed that rural residents who died of an acute myocardial infarction (MI) were nearly three times more likely to be dead on arrival than their urban counterparts. According to the study, which will be presented at the American Heart Association Scientific Sessions 2026, rural residents also had higher odds of dying at home or in outpatient/emergency settings. Johanna Paola Contreras, MD, of the Icahn School of Medicine at Mount Sinai, provided expert commentary. The article analyzing these findings was authored by Yonathan Daniel, MD, an internal medicine resident at NYU Grossman School of Medicine.
11/04/2026
Blepharoplasty boom: Don't overdo it, surgeons warn
MedPage Today
Blepharoplasty, or eyelid surgery, is gaining popularity with a 19% increase in procedures in 2025, but surgeons warn against overdoing it. Danielle Eytan, MD, a facial plastic and reconstructive surgeon at NYU Langone Health, advises a conservative approach. She states that if not done well, the procedure can drastically change a person's face, and aggressive fat removal can alter the eyes' character. Eytan adds that a feared complication is removing too much skin, which can prevent patients from closing their eyes. A trend involves 'preservation' techniques for more natural results.
Also reporting was: MSN UK
11/04/2026